Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Cansortium Reports Second Quarter 2024 Results


      News provided by

      Cansortium Inc.

      Aug 22, 2024, 16:05 ET

      Share this article

      Share this article


      - Q2 Revenue up 12% YoY to a record $27.3 Million

      - 11th Consecutive Quarter of Positive Cash Flow from Operations

      TAMPA, Fla., Aug. 22, 2024 /PRNewswire/ - Cansortium Inc. (CSE: TIUM.U) (OTCQB: CNTMF) ("Cansortium" or the "Company"), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, today announced financial and operating results for the  quarter ended June 30, 2024. Unless otherwise indicated, all financial results are presented in U.S. dollars.

      "We delivered another quarter of year-over-year revenue growth and positive cash flow generation during the second quarter as we continued to execute on our growth objectives," said CEO Robert Beasley. "We continue to lay the foundation for growth and scalability while remaining excited about the opportunities ahead."

      "In Florida, we have focused on enhancing manufacturing efficiencies and cultivation yields, which has resulted in both an improvement of product quality and cost of goods sold. This has allowed us to retain high profit margins while price competition continues to heat up."

      "Looking ahead, we are excited about our upcoming business combination with RIV Capital and have already begun key integration steps. Our shared focus remains on driving growth and profitability by leveraging our core strengths in cultivation, operating expertise and inventory optimization to drive results for shareholders. We remain laser focused on our existing portfolio in Florida, Pennsylvania and Texas and look forward to closing the RIV Capital agreement in the fourth quarter."

      Q2 2024 Financial Highlights (vs. Q2 2023)

      • Revenue increased 12% to $27.3 million compared to $24.4 million.
      • Florida revenue increased 15% to $23.1 million compared to $20.1 million.
      • Adjusted gross profit1 was $12.3 million or 48.6% of revenue, compared to $10.2 million or 46.4% of revenue.
      • Adjusted EBITDA was $7.7 million compared to $6.8 million, with the increase primarily driven by higher revenues due to additional production and stores. 
      • Cash flow from operations for the three months ended June 30, 2024 was $2.8 million compared to $4.8 million in the prior year primarily due to settlement of tax payments that had been carried over from previous periods.
      • On June 30, 2024, the Company had approximately $8.5 million of cash and cash equivalents and $67.5 million of total debt, with approximately 300 million shares outstanding.

      Recent Operational Highlights

      • In Florida, Cansortium currently operates 35 stores and anticipates opening 4 new stores by Q2 2025.
      • In Pennsylvania, Cansortium completed renovations and expanded its Hanover store, refreshing its look and doubling its size. The store remained operational for the entirety of renovations.
      • The company has begun integration activities with RIV Capital sharing best operational practices and driving efficiencies in advance of the business combination expected to close in Q4 2024.

      About Cansortium Inc.
      Cansortium is a vertically-integrated cannabis company with licenses and operations in Florida, Pennsylvania and Texas. The Company operates under the Fluent™ brand and is dedicated to being one of the highest quality cannabis companies for the communities it serves. This is driven by Cansortium's unrelenting commitment to operational excellence in cultivation, production, distribution and retail. The Company is headquartered in Tampa, Florida.

      Cansortium Inc.'s Common Shares trade on the CSE under the symbol "TIUM.U" and on the OTCQB Venture Market under the symbol "CNTMF". For more information about the Company, please visit www.getFLUENT.com.

      ________________________________________

      1 Adjusted gross profit is a non-IFRS financial measure that does not have any standardized meaning prescribed by IFRS and may not be comparable to similar measures presented by other companies. The Company calculates adjusted gross profit from gross profit plus (minus) the changes in fair value of biological assets, as presented in the consolidated statement of operations.

      Forward-Looking Information
      Certain information in this news release may constitute forward-looking information within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. In some cases, but not necessarily in all cases, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "targets", "expects" or "does not expect", "is expected", "an opportunity exists", "is positioned", "estimates", "intends", "assumes", "anticipates" or "does not anticipate" or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might", "will" or "will be taken", "occur" or "be achieved". In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts but instead represent the Company's expectations, estimates, and projections regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control.

      Forward-looking information is necessarily based on many opinions, assumptions, and estimates that, while considered reasonable by the Company as of the date of this news release, are subject to known and unknown risks, uncertainties, assumptions, and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information, including but not limited to the factors described in the public documents of the Company available at www.sedar.com. These factors are not intended to represent a complete list of the factors that could affect the Company; however, these factors should be considered carefully. There can be no assurance that such estimates and assumptions will prove to be correct. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.
      For further information:  www.getFLUENT.com.

      Company Contact
      Robert Beasley, CEO
      (850) 972-8077
      investors.getFLUENT.com 

      Investor Relations Contact
      [email protected] 

      Cansortium Inc.
      Consolidated Statements of Financial Position
      As of June 30, 2024, and December 31, 2023
       (Amounts expressed in thousands of United States Dollars unless otherwise stated)






       June 30, 


       December 31, 






      2024


      2023


      Assets








      Current assets








      Cash




      $                  8,483


      $                 10,521


      Trade receivable




      83


      215


      Inventory, net


      Note 3


      13,400


      9,244


      Biological assets


      Note 4


      4,279


      331


      Prepaid expenses and other current assets


      Note 5


      2,705


      1,882


      Total current assets




      28,950


      22,193










      Property and equipment, net


      Note 6


      26,138


      27,642


      Intangible assets, net


      Note 7


      94,845


      93,593


      Right-of-use assets, net


      Note 12


      32,187


      31,943


      Goodwill


      Note 8


      1,525


      1,525


      Other assets




      997


      907


      Total assets




      $           184,642


      $              177,803










      Liabilities








      Current liabilities








      Trade payable




      $                  5,676


      $                     5,525


      Accrued liabilities




      10,445


      9,779


      Income taxes payable




      28,666


      22,009


      Derivative liabilities


      Note 10


      1,715


      9,109


      Current portion of notes payable, net


      Note 11


      62,063


      213


      Current portion of lease liabilities


      Note 12


      3,081


      2,872


      Total current liabilities




      111,646


      49,507










      Notes payable, net


      Note 11


      5,489


      61,189


      Lease liabilities


      Note 12


      37,944


      37,242


      Deferred tax liability




      20,365


      17,398


      Other long-term liabilities


      Note 20


      3,447


      3,882


      Total liabilities




      178,891


      169,218










      Shareholders' equity








      Share capital


      Note 13


      183,690


      183,690


      Share-based compensation reserve




      6,931


      6,739


      Equity conversion feature




      6,867


      6,677


      Warrants


      Notes 13


      29,634


      29,634


      Accumulated deficit




      (221,037)


      (217,821)


      Foreign currency translation reserve




      (334)


      (334)


      Total shareholders' equity 




      5,751


      8,585










      Total liabilities and shareholders' equity




      $           184,642


      $              177,803

      Cansortium Inc.
      Statement of Operations
      For the three- and six-months ending June 30, 2024 and 2023 
       (Amounts expressed in thousands of United States Dollars unless otherwise stated)





       For the three months ended


       For the six months ended





      June 30,
      2024


      June 30,
      2023


      June 30,
      2024


      June 30,
      2023

      Revenue, net of discounts




      $              27,269


      $                 24,430


      $              52,496


      $                  46,486

      Cost of goods sold




      13,490


      11,448


      26,456


      23,275

      Gross profit before fair value adjustments




      13,779


      12,982


      26,040


      23,211












      Fair value adjustments on inventory sold




      (1,788)


      2,211


      (160)


      4,552

      Unrealized gain (loss) on changes
         in fair value of biological assets


      Note 4


      8,268


      (3,035)


      9,315


      (8,092)

      Gross profit




      20,259


      12,158


      35,195


      19,671












      Expenses











      General and administrative


      Note 14


      4,607


      2,571


      8,570


      4,883

      Sales and marketing


      Note 14


      6,018


      5,576


      11,452


      9,574

      Depreciation and amortization


      Notes 6,7


      1,780


      1,929


      3,510


      3,777

      Share-based compensation




      142


      177


      191


      415

      Total expenses




      12,547


      10,253


      23,723


      18,649












      Income from operations




      7,712


      1,905


      11,472


      1,022












      Other expense (income)











      Finance costs, net


      Note 19


      4,835


      4,324


      9,546


      8,573

      Gain on change in fair value of derivative liability


      Notes 10


      (5,707)


      (442)


      (7,394)


      (164)

      Loss on disposal of assets




      -


      -


      212


      70

      Loss from termination of a contract




      3


      82


      3


      3

      Other miscellaneous income




      (2)


      -


      -


      67

      Total other (income) expense




      (871)


      3,964


      2,367


      8,549












      Income (loss) before income taxes




      8,583


      (2,059)


      9,105


      (7,527)












      Income tax expense


      Note 9


      7,636


      3,291


      12,321


      5,205












      Net comprehensive income (loss)




      $                       947


      $                  (5,350)


      $               (3,216)


      $               (12,732)












      Net loss per share











      Basic and diluted - continuing operations




      $                     0.00


      $                     (0.02)


      $                  (0.01)


      $                      (0.05)












      Weighted average  number of shares











      Basic number of shares




      299,573,039


      296,938,910


      299,551,203


      286,804,241

      Diluted number of shares




      341,443,706


      352,230,174


      341,763,315


      339,972,379

      Cansortium Inc.
      Consolidated Statements of Cash Flow
      For the six months ended June 30, 2024 and 2023 
       (Amounts expressed in thousands of United States Dollars unless otherwise stated)







       For the six months ended 



      June 30,
      2024

      June 30,
      2023


      Operating activities




      Net loss from continuing operations

      $                              (3,216)

      $                          (12,732)


      Adjustments to reconcile net loss to net cash provided by operating activities:




      Unrealized loss (gain)  on changes in fair value of biological assets

      (9,315)

      8,092


      Realized loss (gain) on changes in fair value of biological assets

      160

      (4,552)


      Share-based compensation

      191

      415


      Depreciation and amortization

      7,473

      8,042


      Accretion and interest of convertible debentures

      284

      266


      Accretion and interest of term loan

      6,802

      6,262


      Interest of equipment loan

      -

      13


      Interest on insurance financing

      30

      -


      Interest on convertible promissory note

      49

      -


      Loss on disposal of assets

      212

      70


      Change in fair market value of derivative

      (7,394)

      (164)


      Interest on lease liabilities

      2,405

      2,037


      Deferred tax expense

      2,898

      (1,517)


      Changes in operating assets and liabilities:




      Trade receivable

      132

      1


      Inventory

      8,132

      7,402


      Biological assets

      (7,081)

      (8,886)


      Prepaid expenses and other current assets

      687

      11


      Right of Use Assets/Liabilities

      (2,525)

      67


      Other assets

      (90)

      (40)


      Trade payable

      152

      (135)


      Accrued liabilities

      666

      (623)


      Other long-term liabilities

      (435)

      (791)


      Income taxes payable

      6,657

      6,722


      Net cash provided by operating activities

      6,874

      9,960






      Investing activities




      Purchases of property and equipment

      (3,902)

      (4,339)


      Purchase of intangible assets

      (1,332)

      -


      Net cash used in investing activities

      (5,234)

      (4,339)






      Financing activities




      Net proceeds from issuance of shares and warrants

      -

      2,993


      Net proceeds from convertible note

      3,000

      -


      Payment of lease obligations

      (1,412)

      (3,188)


      Net proceeds from auto and equipment loan

      48

      -


      Principal repayments of notes payable

      (5,314)

      (4,988)


      Net cash used in financing activities

      (3,678)

      (5,183)


      Net increase (decrease) in cash

      (2,038)

      438


      Cash, beginning of period

      10,521

      8,359


      Cash, end of period

      $                                 8,483

      $                                 8,797

      Cansortium Inc.
      Adjusted EBITDA Calculation
      (Amounts expressed in thousands of United States Dollars unless otherwise stated)


      Three months ended


      June 30,

      June 30,



      2024

      2023

      Variance

      Net loss

      $                                947

      $                        (5,350)

      $                  6,297

      Finance costs, net

      4,835

      4,324

      511

      Income taxes

      7,636

      3,291

      4,345

      Depreciation and amortization

      3,771

      3,887

      (116)

      EBITDA

      $                        17,189

      $                           6,152

      $              11,037






      Three months ended


      June 30,

      June 30,



      2024

      2023

      Variance

      EBITDA

      $                        17,189

      $                           6,152

      $              11,037

      Change in fair value of biological assets

      (6,480)

      824

      (7,304)

      Change in fair market value of derivative

      (5,707)

      (442)

      (5,265)

      Professional Fees

      1,852

      -

      1,852

      One-time employee costs

      454

      -

      454

      Loss on termination of contract

      -

      82

      (82)

      Share-based compensation

      142

      177

      (35)

      Other non-recurring expense/(income)

      240

      -

      240

      Adjusted EBITDA

      $                           7,690

      $                           6,793

      $                       897






      Six months ended


      June 30, 

      June 30,



      2024

      2023

      Variance

      Net loss

      $                        (3,216)

      $                     (12,732)

      $                  9,516

      Finance costs, net

      9,546

      8,573

      973

      Income taxes

      12,321

      5,205

      7,116

      Depreciation and amortization

      7,473

      7,662

      (189)

      EBITDA

      $                        26,124

      $                           8,708

      $              17,416






      Six months ended


      June 30,

      June 30,



      2024

      2023

      Variance

      EBITDA

      $                        26,124

      $                           8,708

      $              17,416

      Change in fair value of biological assets

      (9,155)

      3,540

      (12,695)

      Change in fair market value of derivative

      (7,394)

      (164)

      (7,230)

      Professional Fees

      3,641

      -

      3,641

      One-time employee costs

      614

      -

      614

      Loss on termination of contract

      -

      3

      (3)

      Share-based compensation

      191

      415

      (224)

      Loss on diposal of assets

      212

      -

      212

      Other non-recurring expense/(income)

      241

      137

      104

      Adjusted EBITDA

      $                        14,474

      $                        12,639

      $                  1,835

      SOURCE Cansortium Inc.

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.